Christina Caddy, | |
20 Nw Mission Blvd, L12, Lawton, OK 73507-2226 | |
(253) 228-4035 | |
Not Available |
Full Name | Christina Caddy |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 20 Nw Mission Blvd, Lawton, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053791178 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christina Caddy, 20 Nw Mission Blvd, L12, Lawton, OK 73507-2226 Ph: (253) 228-4035 | Christina Caddy, 20 Nw Mission Blvd, L12, Lawton, OK 73507-2226 Ph: (253) 228-4035 |
News Archive
Genzyme, a Sanofi company, today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of LEMTRADA (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS).
Apexigen, Inc., an emerging biopharmaceutical company focusing on the development of monoclonal antibody therapeutics, announced today that its partner, Simcere Pharmaceutical Group, a leading pharmaceutical company in China, filed an Investigational New Drug application with the State Food and Drug Administration of China to evaluate APX003 as a potential cancer therapy.
The American Society for Aesthetic Plastic Surgery (ASAPS) announces today its support of a new national registry for breast implants that will be compiled by the American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA). This registry will document reported cases of a very rare condition, Anaplastic Large Cell Lymphoma (ALCL), in the presence of breast implants.
Patients with cancer found at the end of the large intestine called the rectum who receive one week of radiation therapy before surgery have a 50 percent reduction in chance that their cancer will return after 10 years, according to a large, randomized study presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Widely used treatments for type 2 diabetes have different effects on the hearts of men and women, even as the drugs control blood sugar equally well in both sexes, according to researchers at Washington University School of Medicine in St. Louis.
› Verified 5 days ago
Sallie Jane Dominey, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5 Sw D Ave, Suite 5, Lawton, OK 73501 Phone: 580-250-1222 Fax: 580-250-1795 | |
Iesha Carter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 602 Sw 38th St, Lawton, OK 73505 Phone: 580-248-5780 | |
Lametrice Oglesby, Counselor Medicare: Not Enrolled in Medicare Practice Location: 602 Sw 38th St, Lawton, OK 73505 Phone: 580-248-5780 | |
Mrs. Vickie Moots, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 8 Nw 56th St, Lawton, OK 73505 Phone: 580-357-6859 | |
Mrs. Robin Wilson Tharrington, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Sw B Ave, Lawton, OK 73501 Phone: 580-583-2493 | |
Monica Brokaw, MS, LMFT CAND Counselor Medicare: Not Enrolled in Medicare Practice Location: 19 Ne 20th St, Lawton, OK 73507 Phone: 580-919-7948 | |
Monique Darchele Reese, Counselor Medicare: Not Enrolled in Medicare Practice Location: 22 Nw Heatherstone Dr, Lawton, OK 73505 Phone: 580-591-2894 |